Ken Griffin Reviva Pharmaceuticals Holdings, Inc. Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 60,000 shares of RVPH stock, worth $68,400. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,000
Previous 106,100
43.45%
Holding current value
$68,400
Previous $135,000
36.3%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding RVPH
# of Institutions
40Shares Held
9.97MCall Options Held
133KPut Options Held
43.9K-
Armistice Capital, LLC New York, NY3.19MShares$3.63 Million0.08% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.83MShares$2.09 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY1.52MShares$1.73 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.03MShares$1.17 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA685KShares$780,6770.01% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $23.3M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...